Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BridgeBio Pharma Inc. June 20, 202580.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Nov 18, 2025 | BridgeBio Pharma Inc. | Open-market sale | −24,007 | $65.23 | $1,565,977 |
| Nov 18, 2025 | BridgeBio Pharma Inc. | Open-market sale | −30,993 | $66.05 | $2,047,088 |
| Nov 17, 2025 | BridgeBio Pharma Inc. | Open-market sale | −36,801 | $66.63 | $2,452,051 |
| Nov 17, 2025 | BridgeBio Pharma Inc. | Open-market sale | −3,798 | $67.06 | $254,694 |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| May 2, 2025 | BridgeBio Pharma Inc. | Open-market sale | −100,000 | $38.50 | $3,850,000 |
Questions about Andrew Lo
What boards is Andrew Lo on?
Andrew Lo sits on the boards of AbCellera Biologics Inc. and BridgeBio Pharma Inc.
How long has Andrew Lo served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.